A new study by the American Medical Association (AMA) reveals that despite an almost 40 percent decrease in opioid prescriptions, overdose deaths are on the rise. What is contributing to this, and what changes can independent physicians expect to see in the future of substance abuse treatment?
Who are the two new recipients of the Nobel Prize in Medicine? Why are Medicare Advantage payments lowering while employer-based health insurance rises? Find the answers to these questions and more in The Rundown, our weekly digest of healthcare’s most important issues!
What does the bipartisan, near-unanimous new legislation mean for the opioid crisis? Why did the Department of Justice halt the CVS Health-Aetna merger? Find the answers to these questions and more in The Rundown, our weekly digest of healthcare’s most important issues!
Busy provider looking for healthcare news? Check out The Rundown. FDA Await DEA Decision on Marijuana Pharmaceutical The US Food and Drug Administration (FDA) approved the first cannabidiol (CBD) for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of epilepsy. Approval of the marijuana-derived drug, Epidiolex, followed three randomized, placebo-controlled studies on …